"A. Yes. So on Kesimpta\u00ae, I think the important thing is that we're really leaving no stone unturned in this launch. And as I mentioned before, I think we're in pretty good shape on all our metrics to really bring this product as a first-line DMT to market. We are however feeling the effects of the pandemic, and you can see that mostly in the overall ability of our teams to perform their patient visits."